Dr. Stephen G. Odaibo is a Retina specialist, Mathematician, Computer Scientist, and Full-Stack AI Engineer. He is the first Ophthalmologist in the world to hold advanced degrees in both Mathematics and Computer Science. In 2017 UAB College of Arts & Sciences awarded Dr. Odaibo its highest honor: The Distinguished Alumni Achievement Award. In 2005 he won the Barrie Hurwitz Award for Excellence in Clinical Neurology at Duke Univ. School of Medicine where he topped the class in Neurology and in Pediatrics. Dr. Odaibo has been awarded U.S. Patents for inventing an AI system to automatically diagnose eye diseases from images. Also, he has extensive expertise in the design and conduct of pivotal clinical trials for AI medical devices. He is author of three mathematics textbooks, "Quantum Mechanics and the MRI Machine" (2012), "The Form of Finite Groups: A Course on Finite Group Theory" (2016), and "The Foundational Mathematics of Artificial Intelligence" (2024). Dr. Odaibo serves on the Advisory Board of Data Science Nigeria and the Industry Advisory Board of Duke University's Artificial Intelligence Master of Engineering Program. Dr. Odaibo is a medical device software development, quality, and regulatory expert with extensive leadership experience. He served as summit chair and led the AI workshops at the Medical Device Software Development Summits in the United States (2022, 2023, 2024) and European Union (2023). Also, Dr. Odaibo is also a Google-Certified Professional Cloud Security Engineer and he chaired the Cybersecurity for Medical Devices summit in 2024. Dr. Odaibo continues to enjoy providing excellent clinical care for retina patients. Clinically, he specializes in the diagnosis and management of diabetic retinopathy, age-related macular degeneration, and other retinal diseases.

Tosin Smith, MD completed a residency in Ophthalmology at Howard University Hospital Washington, DC and went on to the Wills Eye Hospital in Philadelphia, PA where she did a fellowship in Glaucoma. She is currently a partner clinician and surgeon at the Glaucoma Associates of Texas in Dallas and Clinical Associate Professor of Ophthalmology at the UTSW Medical College, Dallas, Texas. She is actively involved in clinical research, has numerous publications, serves on many advisory boards and is an active volunteer of many professional societies including the American Academy of Ophthalmology and American Glaucoma Society. She is involved with various aspects of global education and outreach.

Dr. Gregory Sorensen is a board-certified neuroradiologist and from 2011 to 2015 he served as President and Chief Executive Officer of Siemens Healthcare North America, the world’s largest provider of hospital infrastructure, including active businesses in diagnostic imaging, in-vitro diagnostics, and healthcare IT. Prior to Siemens, he was a Professor at Harvard Medical School with additional appointments at the Massachusetts Institute of Technology and Oxford University, and an accomplished physician-scientist, based at Massachusetts General Hospital. 

Greg is the Chief Executive Officer at DeepHealth, Inc., which is now the AI division of RadNet Inc (Nasdaq: RDNT), focused on using machine learning to bring the best doctor in the world to every patient. He also serves as Executive Chairman of IMRIS (Intraoperative MRI Systems specifically for imaging during surgical procedures) and on the supervisory boards of Fresenius Medical Care and Siemens Healthineers.  

He holds an MD degree from Harvard Medical School, a M.S. in computer science from Brigham Young University, and a B.S. in biology from California Institute of Technology. 

Mr. Michael Kaswan has over 25 years of experience as a senior finance executive, venture capital investor, chief executive officer, and board member, working with rapidly growing companies in the healthcare and other industries.
Mike is passionate about entrepreneurship and business value creation, having conceived and written the business plans for two companies that achieved cash exits for a combined $1.4 billion, been a co-founder of a venture capital firm that raised over $290 million in investment capital and created and run a “start-up by acquisition” with over 200 employees.